Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

被引:20
|
作者
DiIorio, Michael [1 ,2 ,3 ]
Kennedy, Kevin [4 ]
Liew, Jean W. [5 ]
Putman, Michael S. [6 ]
Sirotich, Emily [7 ]
Sattui, Sebastian E. [8 ]
Foster, Gary [7 ,9 ]
Harrison, Carly [10 ]
Larche, Maggie J. [11 ,12 ]
Levine, Mitchell [13 ]
Moni, Tarin T. [14 ]
Thabane, Lehana [13 ]
Bhana, Suleman [15 ]
Costello, Wendy [16 ]
Grainger, Rebecca [17 ]
Machado, Pedro M. [18 ,19 ]
Robinson, Philip C. [20 ,21 ]
Sufka, Paul [22 ]
Wallace, Zachary S. [2 ,23 ,24 ]
Yazdany, Jinoos [25 ]
Gore-Massy, Monique [26 ]
Howard, Richard A. [27 ]
Kodhek, More A. [28 ]
Lalonde, Nadine [29 ]
Tomasella, Laura-Ann [30 ]
Wallace, John [31 ]
Akpabio, Akpabio [32 ]
Alpizar-Rodriguez, Deshire [33 ]
Beesley, Richard P. [34 ]
Berenbaum, Francis [35 ]
Bulina, Inita [36 ]
Chock, Eugenia Yupei [37 ]
Conway, Richard [38 ]
Duarte-Garcia, Ali [39 ]
Duff, Eimear [40 ]
Gheita, Tamer A. [41 ]
Graef, Elizabeth R. [42 ]
Hsieh, Evelyn [43 ,44 ]
El Kibbi, Lina [45 ]
Liew, David F. L. [46 ,47 ]
Lo, Chieh [48 ]
Nudel, Michal [49 ]
Singh, Aman Dev [50 ,51 ]
Singh, Jasvinder A. [52 ,53 ]
Singh, Namrata [54 ]
Ugarte-Gil, Manuel F. [55 ,56 ]
Hausmann, Jonathan S. [57 ,58 ]
Simard, Julia F. [59 ,60 ,61 ]
Sparks, Jeffrey A. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA
[4] McMaster Univ, Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[5] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA 02118 USA
[6] Med Coll Wisconsin, Div Rheumatol, Milwaukee, WI 53226 USA
[7] McMaster Univ, Med, Hamilton, ON, Canada
[8] Univ Pittsburgh Med Ctr, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA
[9] McMaster Univ, Dept Hlth Res Methods Evidence & Impact HEI, Hamilton, ON, Canada
[10] LupusChat, New York, NY USA
[11] McMaster Univ, Div Clin Immunol, Dept Med, Hamilton, ON, Canada
[12] McMaster Univ, Div Allergy Rheumatol, Dept Med, Hamilton, ON, Canada
[13] McMaster Univ, Dept Hlth Res Methods Evidence & Impact HEI, Fac Hlth Sci, Hamilton, ON, Canada
[14] McMaster Univ, Dept Biochem & Biomed Sci, Fac Sci, Hamilton, ON, Canada
[15] Crystal Run Healthcare, Rheumatol, Middletown, NY USA
[16] Irish Childrens Arthrit Network iCAN, Tipperary, Ireland
[17] Univ Otago Wellington, Dept Med, Wellington, New Zealand
[18] UCL, MRC Ctr Neuromuscular Dis, London, England
[19] UCL, Ctr Rheumatol, Rheumatol, London, England
[20] Univ Queensland, Fac Med, Herston, Qld, Australia
[21] Royal Brisbane & Womans Hosp Hlth Serv Dist, Metro North Hosp & Hlth Serv, Herston, Qld, Australia
[22] HealthPartners, Rheumatol, St Paul, MN USA
[23] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Clin Epidemiol Program, Boston, MA 02114 USA
[24] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Rheumatol Unit, Boston, MA 02114 USA
[25] Univ Calif San Francisco, Med Rheumatol, San Francisco, CA 94143 USA
[26] Lupus Fdn Amer Inc, Washington, DC USA
[27] Spondylitis Assoc Amer, Van Nuys, CA USA
[28] Lupus Fdn Kenya, Nairobi, Kenya
[29] Covid 19 Global Rheumatol Alliance, Patient Board, London, ON, Canada
[30] Arthrit Kids South Africa, Johannesburg, South Africa
[31] Autoinflammatory UK, Rheumatol, Edinburgh, Midlothian, Scotland
[32] Univ Uyo Teaching Hosp, Internal Med, Uyo, Nigeria
[33] Mexican Coll Rheumatol, Res Unit, Coyoacan, Mexico
[34] European Network Childhood Arthrit ENCA, Juvenile Arthrit Res, Tonbridge, England
[35] Sorbonne Univ, Rheumatol, Paris, France
[36] Paul Stradins Clin Univ Hosp, Rheumatol, Riga, Latvia
[37] Yale Sch Med, Sect Rheumatol, New Haven, CT USA
[38] St James Hosp, Dept Rheumatol, Dublin, Ireland
[39] Mayo Clin, Div Rheumatol, Rochester, MN USA
[40] St James Hosp, Rheumatol, Dublin, Ireland
[41] Cairo Univ, Fac Med, Rheumatol & Clin Immunol, Cairo, Egypt
[42] Beth Israel Deaconess Med Ctr, Rheumatol, Boston, MA 02215 USA
[43] Yale Sch Med, Div Rheumatol, New Haven, CT USA
[44] VA Connecticut Healthcare Syst, Rheumatol, West Haven Campus, West Haven, CT USA
[45] Specialized Med Ctr Hosp, Internal Med Dept, Div Rheumatol, Riyadh, Saudi Arabia
[46] Austin Hlth, Rheumatol, Heidelberg West, Vic, Australia
[47] Austin Hlth, Clin Pharmacol & Therapeut, Heidelberg, Vic, Australia
[48] I Shou Univ, Coll Med, Rheumatol, Yanchau Sheng, Taiwan
[49] Israeli Assoc RMDs Patients Mifrakim Tzeirim, Haifa, Israel
[50] Govt Med Coll Amritsar, Dept Community Med, Amritsar, Punjab, India
来源
RMD OPEN | 2022年 / 8卷 / 02期
关键词
COVID-19; patient reported outcome measures; inflammation; vaccination;
D O I
10.1136/rmdopen-2022-002587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28 days or longer, among people with systemic autoimmune rheumatic diseases (SARDs). Methods We analysed data from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2 April 2021-15 October 2021) to identify people with SARDs reporting test-confirmed COVID-19. Participants reported COVID-19 severity and symptom duration, sociodemographics and clinical characteristics. We reported the proportion experiencing prolonged symptom duration and investigated associations with baseline characteristics using logistic regression. Results We identified 441 respondents with SARDs and COVID-19 (mean age 48.2 years, 83.7% female, 39.5% rheumatoid arthritis). The median COVID-19 symptom duration was 15 days (IQR 7, 25). Overall, 107 (24.2%) respondents had prolonged symptom duration (>= 28 days); 42/429 (9.8%) reported symptoms lasting >= 90 days. Factors associated with higher odds of prolonged symptom duration included: hospitalisation for COVID-19 vs not hospitalised and mild acute symptoms (age-adjusted OR (aOR) 6.49, 95% CI 3.03 to 14.1), comorbidity count (aOR 1.11 per comorbidity, 95% CI 1.02 to 1.21) and osteoarthritis (aOR 2.11, 95% CI 1.01 to 4.27). COVID-19 onset in 2021 vs June 2020 or earlier was associated with lower odds of prolonged symptom duration (aOR 0.42, 95% CI 0.21 to 0.81). Conclusion Most people with SARDs had complete symptom resolution by day 15 after COVID-19 onset. However, about 1 in 4 experienced COVID-19 symptom duration 28 days or longer; 1 in 10 experienced symptoms 90 days or longer. Future studies are needed to investigate the possible relationships between immunomodulating medications, SARD type/flare, vaccine doses and novel viral variants with prolonged COVID-19 symptoms and other postacute sequelae of COVID-19 among people with SARDs.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
    Sattui, Sebastian Eduardo
    Liew, Jean W.
    Kennedy, Kevin
    Sirotich, Emily
    Putman, Michael
    Moni, Tarin T.
    Akpabio, Akpabio
    Alpizar-Rodriguez, Deshire
    Berenbaum, Francis
    Bulina, Inita
    Conway, Richard
    Singh, Aman Dev
    Duff, Eimear
    Durrant, Karen L.
    Gheita, Tamer A.
    Hill, Catherine L.
    Howard, Richard A.
    Hoyer, Bimba F.
    Hsieh, Evelyn
    El Kibbi, Lina
    Kilian, Adam
    Kim, Alfred Hyoungju
    Liew, David F. L.
    Lo, Chieh
    Miller, Bruce
    Mingolla, Serena
    Nudel, Michal
    Palmerlee, Candace A.
    Singh, Jasvinder A.
    Singh, Namrata
    Ugarte-Gil, Manuel Francisco
    Wallace, John
    Young, Kristen J.
    Bhana, Suleman
    Costello, Wendy
    Grainger, Rebecca
    Machado, Pedro M.
    Robinson, Philip C.
    Sufka, Paul
    Wallace, Zachary S.
    Yazdany, Jinoos
    Harrison, Carly
    Larche, Maggie
    Levine, Mitchell
    Foster, Gary
    Thabane, Lehana
    Rider, Lisa G.
    Hausmann, Jonathan S.
    Simard, Julia F.
    Sparks, Jeffrey A.
    [J]. RMD OPEN, 2021, 7 (03):
  • [2] COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
    Putman, Michael
    Kennedy, Kevin
    Sirotich, Emily
    Liew, Jean W.
    Sattui, Sebastian E.
    Moni, Tarin T.
    Akpabio, Akpabio A.
    Alpizar-Rodriguez, Deshire
    Angevare, Saskya
    Beesley, Richard P.
    Berenbaum, Francis
    Bulina, Inita
    Chock, Yu Pei Eugenia
    Conway, Richard
    Duarte-Garcia, Ali
    Singh, Aman Dev
    Duff, Eimear
    Durrant, Karen L.
    Gheita, Tamer A.
    Hill, Catherine L.
    Howard, Richard
    Hoyer, Bimba F.
    Hsieh, Evelyn
    el Kibbi, Lina
    Kilian, Adam
    Kim, Alfred H. J.
    Liew, David F. L.
    Lo, Chieh
    Mateus, Elsa F.
    Miller, Bruce
    Mingolla, Serena
    Nudel, Michal
    Singh, Jasvinder A.
    Singh, Namrata
    Ugarte-Gil, Manuel F.
    Wallace, John
    Young, Kristen J.
    Zamora-Tehozol, Erick Adrian
    Bhana, Suleman
    Costello, Wendy
    Grainger, Rebecca
    Machado, Pedro M.
    Robinson, Philip C.
    Sufka, Paul
    Wallace, Zachary S.
    Yazdany, Jinoos
    Harrison, Carly
    Larche, Maggie J.
    Levine, Mitchell
    Foster, Gary
    [J]. LANCET RHEUMATOLOGY, 2022, 4 (04): : E237 - E240
  • [3] THE IMPACT OF COVID-19 ON RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY
    Young, K.
    Yeoh, S. A.
    Putman, M.
    Graef, E.
    Berenbaum, F.
    Conway, R.
    Grainger, R.
    Kilian, A.
    Konig, M.
    Liew, J.
    Machado, P. M.
    Sattui, S. E.
    Sparks, J.
    Sufka, P.
    Ugarte-Gil, M.
    Upton, L.
    Wallace, Z.
    Yazdany, J.
    Jayatilleke, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 230 - 231
  • [4] Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry
    Conway, Richard
    Nikiphorou, Elena
    Demetriou, Christiana A.
    Low, Candice
    Leamy, Kelly
    Ryan, John G.
    Kavanagh, Ronan
    Fraser, Alexander D.
    Carey, John J.
    O'Connell, Paul
    Flood, Rachael M.
    Mullan, Ronan H.
    Kane, David J.
    Ambrose, Nicola
    Stafford, Frances
    Robinson, Philip C.
    Liew, Jean W.
    Grainger, Rebecca
    McCarthy, Geraldine M.
    [J]. RHEUMATOLOGY, 2022, 61 (SI2) : SI151 - SI156
  • [5] The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey
    Young, Kristen
    Yeoh, Su-Ann
    Putman, Michael
    Sattui, Sebastian
    Conway, Richard
    Graef, Elizabeth
    Kilian, Adam
    Konig, Maximilian
    Sparks, Jeffrey
    Ugarte-Gil, Manuel
    Upton, Laura
    Berenbaum, Francis
    Bhana, Suleman
    Costello, Wendy
    Hausmann, Jonathan
    Machado, Pedro
    Robinson, Philip
    Sirotich, Emily
    Sufka, Paul
    Yazdany, Jinoos
    Liew, Jean
    Grainger, Rebecca
    Wallace, Zachary
    Jayatilleke, Arundathi
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (01)
  • [6] COVID-19 and systemic autoimmune rheumatic diseases
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (02): : E100 - E100
  • [7] The Impact of COVID-19 on Rheumatology Trainee Health and Wellbeing: Results from the COVID-19 Global Rheumatology Alliance Trainee Survey
    Young, Kristen
    Yeoh, Su-Ann
    Putman, Michael
    Sattui, Sebastian
    Conway, Richard
    Graef, Elizabeth
    Killian, Adam
    Konig, Maximilian
    Sparks, Jeffrey
    Ugarte-Gil, Manuel
    Upton, Laura
    Berenbaum, Francis
    Bhana, Suleman
    Hausmann, Jonathan
    Machado, Pedro
    Robinson, Philip
    Sirotich, Emily
    Sufka, Paul
    Yazdany, Jinoos
    Liew, Jean
    Grainger, Rebecca
    Wallace, Zachary
    Jayatilleke, Aruni
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1002 - 1004
  • [8] COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance
    Bermas, Bonnie L.
    Gianfrancesco, Milena
    Tanner, Helen L.
    Seet, Andrea M.
    Aguiar, Mathia C.
    Al Adhoubi, Nasra K.
    Al Emadi, Samar
    Cunha, Bernardo M.
    Flood, Rachael
    Kusevich, Daria A.
    McCarthy, Eoghan M.
    Patel, Naomi J.
    Ruderman, Eric M.
    Sattui, Sebastian E.
    Sciascia, Savino
    Siddique, Faizah
    Valenzuela-Almada, Maria O.
    Wise, Leanna M.
    Worthing, Angus B.
    Zel, JoAnn
    Bhana, Suleman
    Costello, Wendy
    Duarte-Garcia, Ali
    Grainger, Rebecca
    Gossec, Laure
    Hausmann, Jonathan S.
    Hyrich, Kimme
    Lawson-Tovey, Saskia
    Liew, Jean W.
    Sirotich, Emily
    Sparks, Jeffrey A.
    Sufka, Paul
    Wallace, Zachary S.
    Machado, Pedro M.
    Strangfeld, Anja
    Clowse, Megan E. B.
    Yazdany, Jinoos
    Robinson, Philip C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2022, 49 (01) : 110 - 114
  • [9] COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance
    Bermas, Bonnie
    Clowse, Megan
    Gianfrancesco, Milena
    Hausmann, Jonathan
    Machado, Pedro M.
    Sirotich, Emily
    Robinson, Helen
    Strangfeld, Anja
    Yazdany, Jinoos
    Robinson, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance
    Maheswaranathan, Mithu
    Miller, Bruce
    Ung, Natasha
    Sinha, Rashmi
    Harrison, Carly
    Egeli, Bugra Han
    Degirmenci, Huseyin Berk
    Sirotich, Emily
    Liew, Jean W.
    Grainger, Rebecca
    Chock, Eugenia Y.
    [J]. CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 543 - 552